Teletherapy Alone Will Not Solve The Mental Health Access Issue
New mental health treatment tools based on technology work, and outcomes are exceptional. Now health plans must expand coverage so more patients can access these new treatments.
The $232 Billion Problem: The Price of Overlooking the Impact of Trauma in the U.S.
When we talk about post-traumatic stress disorder (PTSD), a condition fundamentally born from overwhelming experiences that leave a long-term imprint on the body, our mainstream approach often feels stuck in the past.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
The Miscalculation of Teletherapy: Why Digital Mental Health Goes Beyond Virtual Sessions
It is time we realize that there is no single panacea for mental health; the need to break down barriers for working families and individuals in rural towns or underserved communities requires we move past a narrow definition of telehealth.
The Dangerous Cycle of Anxiety and Diabetes
Effective diabetes management requires a shift from focusing purely on blood sugar levels and weight management medications to embracing the psychological and biological contributors that drive obesity and the disease.
Shock, Fear and Anxiety – The Complexity of Breast Cancer Beyond Diagnosis
Providers should incorporate mental health screenings as a standard part of cancer care for patients and their loved ones.
Parenting: The New Mental Health Threat?
A CEO and father of two reflects on the Surgeon General's recent advisory, evolving pressures on today's parents and the impact on mental health.
presented by
Proposed Medicare Codes a Game-Changer for Digital Health
If enacted, the codes will represent the first major step toward broad-based reimbursement for digital therapeutics, and acknowledgement that CMS recognizes the substantial role new digital solutions can provide.
Why Wait? The Urgency of Accessible PTSD Treatments Now
In our eagerness for innovation, there's a risk that we ignore existing effective, readily-available treatments.